In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

Transcatheter edge-to-edge repair (TEER) with the MitraClip (Abbott) to treat functional and degenerative mitral regurgitation (MR) fails relatively infrequently when performed at high-volume centers, ...

Long-axis view on TEE. PML = posterior mitral leaflet, AML = anterior mitral leaflet (Photo Credit: Hannes Alessandrini) As MitraClip procedures continue to expand as an option for nonsurgical ...

Navi Mumbai: A 78-year-old patient with severe mitral regurgitation has successfully undergone the MitraClip procedure, ...

BOSTON, MA — Four-year follow-up of the Endovascular Valve Edge-to-Edge Repair Study II (EVEREST II) show no differences in the primary end point between the MitraClip (Abbott) procedure and surgery ...

The Everest II Clinical Trial is a study comparing nonsurgical repair for severe mitral valve regurgitation with conventional surgery. The MitraClip procedure is performed in a cardiac catheterization ...

SAN FRANCISCO — Transcatheter mitral valve repair (TMVR) with the MitraClip (Abbott) is a reasonably cost-effective strategy but not cost-saving, even if the device were free, an economic analysis of ...